In this issue, you'll hear about a surprise ruling that has left the stem-cell community stunned. You'll learn about an experimental drug that is being considered a major breakthrough in cancer treatment. You'll hear how scientists are using data from genome analysis to help them choose the best drugs for their patients. You'll learn how scientists are closing in on a molecular explanation for certain cases of autism. And you’ll hear news from the worlds of Biomedicine, Technology and Communications.
(P) and ©2010 Massachusetts Institute of Technology